IVAZIDE Trademark

Trademark Overview

On Friday, November 30, 2018, a trademark application was filed for IVAZIDE with the United States Patent and Trademark Office. The USPTO has given the IVAZIDE trademark a serial number of 88212472. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 11, 2022. This trademark is owned by Exela Innovations, LLC. The IVAZIDE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of diuresis and hypertension by parenteral administration
ivazide

General Information

Serial Number88212472
Word MarkIVAZIDE
Filing DateFriday, November 30, 2018
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 11, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 9, 2019

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of diuresis and hypertension by parenteral administration

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, December 18, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameExela Innovations, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressLenoir, NC 28645
Party NameExela Innovations, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressLenoir, NC 28645

Trademark Events

Event DateEvent Description
Monday, July 11, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, July 11, 2022ABANDONMENT - NO USE STATEMENT FILED
Wednesday, December 1, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 30, 2021SOU EXTENSION 5 GRANTED
Monday, November 22, 2021SOU EXTENSION 5 FILED
Tuesday, November 30, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, November 22, 2021TEAS EXTENSION RECEIVED
Tuesday, June 8, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, June 4, 2021SOU EXTENSION 4 GRANTED
Friday, June 4, 2021SOU EXTENSION 4 FILED
Friday, June 4, 2021TEAS EXTENSION RECEIVED
Tuesday, December 8, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, December 4, 2020SOU EXTENSION 3 GRANTED
Friday, December 4, 2020SOU EXTENSION 3 FILED
Friday, December 4, 2020TEAS EXTENSION RECEIVED
Saturday, June 6, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 4, 2020SOU EXTENSION 2 GRANTED
Thursday, June 4, 2020SOU EXTENSION 2 FILED
Thursday, June 4, 2020TEAS EXTENSION RECEIVED
Friday, December 6, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 4, 2019SOU EXTENSION 1 GRANTED
Wednesday, December 4, 2019SOU EXTENSION 1 FILED
Wednesday, December 4, 2019TEAS EXTENSION RECEIVED
Tuesday, June 4, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 9, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 9, 2019PUBLISHED FOR OPPOSITION
Wednesday, March 20, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, March 1, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, March 1, 2019ASSIGNED TO EXAMINER
Tuesday, December 18, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, December 4, 2018NEW APPLICATION ENTERED IN TRAM

Related Keywords

ivazide parenteral administration hypertension diuresis preparations treatment pharmaceutical